State of New Jersey Common Pension Fund D - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$2,159,000
-3.5%
685,404
-10.9%
0.01%0.0%
Q2 2020$2,238,000
+3.2%
769,1980.0%0.01%
-18.2%
Q1 2020$2,169,000
-13.1%
769,1980.0%0.01%
+22.2%
Q4 2019$2,496,000
+57.2%
769,198
+4.6%
0.01%
+50.0%
Q3 2019$1,588,000
+817.9%
735,100
+1236.5%
0.01%
+500.0%
Q2 2019$173,000
-15.6%
55,0000.0%0.00%0.0%
Q1 2019$205,000
+28.1%
55,0000.0%0.00%0.0%
Q4 2018$160,000
+10.3%
55,0000.0%0.00%0.0%
Q3 2018$145,000
+12.4%
55,0000.0%0.00%
Q2 2018$129,000
-20.4%
55,0000.0%0.00%
-100.0%
Q1 2018$162,000
+7.3%
55,0000.0%0.00%0.0%
Q4 2017$151,000
-64.4%
55,000
-56.0%
0.00%
-50.0%
Q3 2017$424,000
+37.2%
125,0000.0%0.00%
+100.0%
Q2 2017$309,000
+8.8%
125,0000.0%0.00%0.0%
Q1 2017$284,000
+7.2%
125,0000.0%0.00%0.0%
Q4 2016$265,000
-36.8%
125,0000.0%0.00%
-50.0%
Q3 2016$419,000
+6.6%
125,0000.0%0.00%0.0%
Q2 2016$393,000
-5.5%
125,0000.0%0.00%0.0%
Q1 2016$416,000
-53.0%
125,000
-50.0%
0.00%0.0%
Q4 2015$886,000
+40.9%
250,000
+100.0%
0.00%
-33.3%
Q3 2015$629,000
-21.8%
125,0000.0%0.00%0.0%
Q2 2015$804,000
-8.5%
125,0000.0%0.00%0.0%
Q1 2015$879,000
-8.8%
125,0000.0%0.00%
-25.0%
Q4 2014$964,000
+3.2%
125,0000.0%0.00%0.0%
Q3 2014$934,000
-22.8%
125,0000.0%0.00%
-20.0%
Q2 2014$1,210,000125,0000.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders